Public Access Database for Medical Device Registration

Registration does not represent any form of accreditation, certification or approval by the UK Competent Authority(MHRA)
Where a conformity assessment certificate is listed as expired, existing products already placed on the market prior to the expiry may not be affected by this expiry and can continue to be used. This expiry stops new products being placed on the market until there is a new certificate of conformity

Manufacturer's By Name

By Device

Back to MHRA

Manufacturer's Devices - Invivoscribe Inc

Address:

Invivoscribe Inc 10222 Barnes Canyon Road Bldg. 1

San Diego

California 92121-2711

United States

Authorised Representative/ UK Responsible Person
Name: Gillian Pawlowsky Ltd
Address:

272 Bath Street

Glasgow

G2 4JR

Scotland United Kingdom

Code/Term Type

Acute myeloid leukaemia (AML) genetic mutation IVD kit nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD kit nucleic acid technique (NAT) IVD General

T-cell lymphoma IVD kit nucleic acid technique (NAT) T-cell lymphoma IVD kit nucleic acid technique (NAT) IVD General

B-cell malignancy IVD kit nucleic acid technique (NAT) B-cell malignancy IVD kit nucleic acid technique (NAT) IVD General

Contact details

Freedom of information

0203 080 7272 (manned 10:00-16:00 hours working days) device.registrations@mhra.gov.uk

© 2011 Crown Copyright. To contact us about this website, use our feedback form.

Code/Term		Type
Acute myeloid leukaemia (AML) genetic mutation IVD kit nucleic acid technique (NAT)	Acute myeloid leukaemia (AML) genetic mutation IVD kit nucleic acid technique (NAT)	IVD General
T-cell lymphoma IVD kit nucleic acid technique (NAT)	T-cell lymphoma IVD kit nucleic acid technique (NAT)	IVD General
B-cell malignancy IVD kit nucleic acid technique (NAT)	B-cell malignancy IVD kit nucleic acid technique (NAT)	IVD General